Upgrade to SI Premium - Free Trial

ResMed (RMD) PT Raised to $236 at Needham

April 26, 2024 5:57 AM
(Updated - April 26, 2024 5:57 AM EDT)

Needham analyst Mike Matson raised the price target on ResMed (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change